Gilead working with generics firms to boost global supply of...

Gilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet global demand. 

4 tips for switching to virtual meetings

Coronavirus has forced pharma companies to take their meetings online – including everything from small team calls to major congresses.

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial. 

BerGenBio raises 45 million euros for COVID-19 drug developm...

Norway’s BerGenBio has raised 500 million Norwegian kroner – around $45.4 million euros – in an oversubscribed private placement to develop its pipeline that includes a potential COVID-19 t

UK says coronavirus contact tracing app could be nationwide ...

Hepatitis drug could be tested against COVID-19 in India

India’s Zydus Cadila wants to test a form of interferon, usually used against hepatitis B and C, as a potential treatment for the virus that causes COVID-19.